We are thrilled to announce a new publication, Structure-activity relationship of dihydropyridines for rhabdomyosarcoma, showcasing results of a study of a massive drug & chemical

Leave a legacy by inspiring young minds with cc-TDI Student Internships! Each summer cc-TDI proudly offers six to twelve internships for students ages 14 years

Today we bid farewell to Mattie, who has been with cc-TDI for two and a half years during which time she has become an invaluable

From the moment I heard the words, “You will complete a community project as an eighth-grade graduation requirement,” I immediately knew my project would be

It is with grieving hearts that we share the news that our beloved Board Member Richard Levick passed away from his battle with cancer. Charles

We are excited to announce a landmark publication just released in the British Journal of Cancer! A link to the article can be found here.

When cc-TDI was founded 8 years ago, Matthew Svalina was the first staff scientist hired to help get cc-TDI’s mission up and running. Below is

The Megan’s Mission Foundation Awards $100,000 in Rhabdomyosarcoma Research Funding  The Children’s Cancer Therapy Development Institute (cc-TDI) was generously awarded $100,000 in support of two

Executive Director, Children’s Cancer Therapy Development Institute (Beaverton, OR) Join the team of “rebel scientists” at cc-TDI who are pushing the boundaries of scientific innovation

The Children’s Cancer Therapy Development Institute (cc-TDI) was awarded $100,000 in support of Diffuse Intrinsic Pontine Glioma (DIPG) research by The Lyla Nsouli Foundation for